BCGM Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
BCGM Wealth Management's LLY Position: Q1 2026 in Review
BCGM Wealth Management reduced its Eli Lilly (LLY) stake by 0.43% in Q1 2026, selling an estimated $21.3K and leaving 4,909 shares worth $4.51M. The position accounts for 1.13% of the portfolio, ranked #28.
BCGM Wealth Management first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.3M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- BCGM Wealth Management held 4,909 shares of Eli Lilly worth $4.51M as of Q1 2026.
- BCGM Wealth Management sold 21 Eli Lilly shares in Q1 2026, an estimated $21.3K.
- Eli Lilly made up 1.13% of BCGM Wealth Management's portfolio in Q1 2026, its #28 holding.
- BCGM Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
- BCGM Wealth Management's Eli Lilly position peaked at $5.3M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on BCGM Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.